Key facts
- Arch Biopartners was featured in the American Diabetes Association's Thought Leadership Series.
- The event took place at the 2026 Scientific Sessions in New Orleans.
- The company has 67,933,289 common shares outstanding.
Arch Biopartners announced its participation in the American Diabetes Association's Thought Leadership Series, which was held at the 2026 Scientific Sessions in New Orleans. The company also disclosed that it has 67,933,289 common shares outstanding.